Art Technology Acquisition Corp.

Art Technology Acquisition Corp.

NNASDAQ:ARTC
10.03
USD
+0.01
(+0.06%)
348.68MMarket Cap
Art Technology Acquisition Corp.
NASDAQ:ARTC
(Nasdaq Stock Market)

Recent

price

10.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2025
TTM
USD
- -
- -
Revenue per Share
- -
- -
Basic EPS, GAAP
- -
- -
Free Cash Flow per Basic Share
- -
- -
Dividend per Share
- -
7.19
Book Value per Share
- -
7.19
Tangible Book Value per Share
35
33
Basic Weighted Avg Shares
- -
- -
Sales/Revenue/Turnover
- -
- -
Operating Margin (%)
- -
- -
Depreciation Expense
- -
- -
Net Income, GAAP
- -
- -
Effective Tax Rate (%)
- -
- -
Profit Margin (%)
- -
2
Working Capital
- -
- -
LT Debt
- -
251
Total Equity
- -
- -
Return on Invested Capital (%)
- -
- -
Return on Capital (%)
- -
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Jun'26
Sep'26
ST Debt
- -
- -
LT Borrowings
- -
- -
LT Finance Leases
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
Shares Outstanding
35
35
Market Capitalization
346
349

Working Capital

USD

•

in mil. unless spec.
Jun'26
Sep'26
Total Current Assets
2
2
Cash, Cash Equivalents & STI
2
2
Accounts Receivable, Net
- -
- -
Inventories
- -
- -
Total Current Liabilities
- -
- -
Payables & Accruals
- -
- -
ST Debt
- -
- -
Deferred Revenue
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
0.05
0.06
0.05
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
ArthroCare Corp. (ARTC) develops, manufactures, and markets minimally invasive surgical devices based on its patented Coblation radiofrequency technology, which dissolves soft tissue while minimizing damage to surrounding healthy areas; core products include sports medicine offerings such as disposable ArthroWands for arthroscopic procedures on knees, shoulders, hips, ankles, elbows, and wrists, along with soft-tissue fixation anchors, screws for ligament reconstruction, and suture passers; ear, nose, and throat (ENT) solutions like suction, channeling, and excision wands, the ENTact septal stapler, SerpENT articulating instruments, Ventera sinus dilation systems, Rapid Rhino carboxymethyl-cellulose packing, Stammberger sinus dressings, and epistaxis balloon tamponade products; spine devices including SpineWands, Plasma Disc Decompression tools for herniated discs, Cavity SpineWands for vertebral fractures and tumors, and WoundWands for debridement; as well as urology, gynecology, and wound care instruments. The company, founded in 1993 by Hira V. Thapliyal and Philip E. Eggers and originally headquartered in Sunnyvale, California before relocating to Austin, Texas, operates primarily in the Americas through direct sales representatives and internationally via distributors targeting surgeons and specialized medical professionals in orthopedics, ENT, spine, and related segments. In 2014, ArthroCare was acquired by Smith & Nephew plc for $1.5 billion in enterprise value and now operates as its subsidiary, integrating Coblation technology into a broader resection, repair, and ENT portfolio with anticipated synergies exceeding $85 million annually by the third full year post-acquisition, including expanded global market access and enhanced R&D pipelines.

Company News

  • Art Technology Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026

  • ARTCU’s (NASDAQ:ARTCU) Quiet Period Set To Expire on February 16th

  • Art Technology Acquisition Corp. Announces the Closing of Full Exercise of IPO Over-Allotment Option

  • Art Technology Acquisition Corp. Announces the Closing of $220 Million Initial Public Offering